Referred to the House Committee on Energy and Commerce.
The Second Chance at Life Act of 2025 amends the Public Health Service Act to require that providers who perform mifepristone-based chemical abortions give pre-procedure verbal notice (at least 24 hours prior) and written discharge instructions stating that reversal of mifepristone’s effects may be possible if the second drug has not been taken. The bill mandates conspicuous signage at facilities, directs HHS to publish multilingual printed materials and to create a specified website with accessibility and formatting requirements, and creates a civil cause of action (including actual and punitive damages and fee-shifting) for patients, fathers of the unborn child, or parents of minors when providers knowingly or recklessly violate the law, subject to a medical-emergency exception.
Medical validity of "abortion pill reversal": liberals see it as unproven and risky to promulgate; conservatives treat it as a legitimate option to inform patients about.
Relative to its intended legislative type, this bill is a clearly focused substantive policy change that is highly specific about the required disclosures, signage, website content and format, and civil remedies.
The Second Chance at Life Act of 2025 amends the Public Health Service Act to require that providers who perform mifepristone-based chemical abortions give pre-procedure verbal notice (at least 24 hours prior) and written discharge instructions stating that reversal of mifepristone’s effects may be possible if the second drug has not been taken.
The bill mandates conspicuous signage at facilities, directs HHS to publish multilingual printed materials and to create a specified website with accessibility and formatting requirements, and creates a civil cause of action (including actual and punitive damages and fee-shifting) for patients, fathers of the unborn child, or parents of minors when providers knowingly or recklessly violate the law, subject to a medical-emergency exception.
The Act includes definitions, a non-preemption clause allowing more stringent state laws, and a severability provision.
On content alone, the bill touches a politically charged subject and prescribes medically contested statements and civil liabilities that create clear points of conflict. It lacks compromise mechanisms (funding offsets, pilot programs, sunset), and would be vulnerable to legal and scientific debate. While a bill of this scope can pass one chamber in favorable conditions, becoming law would require overcoming substantial institutional and political hurdles in both chambers and avoiding legal challenges; based solely on the text and typical legislative dynamics, the chance of final enactment is modest-to-low.
Relative to its intended legislative type, this bill is a clearly focused substantive policy change that is highly specific about the required disclosures, signage, website content and format, and civil remedies. It includes definitional detail, deadlines, and an emergency exception, and it assigns responsibilities to both providers and the Secretary of HHS.
Medical validity of "abortion pill reversal": liberals see it as unproven and risky to promulgate; conservatives treat it as a legitimate option to inform patients about.
These are examples from the analysis, not a ranked list of the most-affected groups.
Medical validity of "abortion pill reversal": liberals see it as unproven and risky to promulgate; conservatives treat it as a legitimate option to inform patients about.
This persona would likely view the bill skeptically and broadly oppose it.
They would see the mandated messaging about "abortion pill reversal" as promoting a contested and largely discredited medical claim, risking the spread of misinformation and potentially endangering patients.
They would also object to expanded civil liability (including fathers’ standing to sue) and to requirements that could chill or complicate access to abortion care.
A centrist would likely have a mixed reaction.
They may accept the general principle that patients should receive relevant information before a procedure but worry that the statute mandates medically contested content and creates significant legal and administrative burdens.
The unusual prescriptive website/format rules and broad civil remedies would raise concerns about implementation, costs, and unintended consequences.
This persona would likely view the bill favorably as protecting unborn life and expanding information available to women who might change their mind after beginning a chemical abortion.
They would support legal mechanisms that hold providers accountable for failing to inform patients and view the signage, written instructions, and HHS materials as appropriate transparency measures.
They would see the civil remedies and preemption clause (allowing states to go further) as strengths that promote enforcement and state-level protections.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill touches a politically charged subject and prescribes medically contested statements and civil liabilities that create clear points of conflict. It lacks compromise mechanisms (funding offsets, pilot programs, sunset), and would be vulnerable to legal and scientific debate. While a bill of this scope can pass one chamber in favorable conditions, becoming law would require overcoming substantial institutional and political hurdles in both chambers and avoiding legal challenges; based solely on the text and typical legislative dynamics, the chance of final enactment is modest-to-low.
The bill has not accumulated any surfaced votes yet.
Medical validity of "abortion pill reversal": liberals see it as unproven and risky to promulgate; conservatives treat it as a legitimate o…
On content alone, the bill touches a politically charged subject and prescribes medically contested statements and civil liabilities that c…
Relative to its intended legislative type, this bill is a clearly focused substantive policy change that is highly specific about the required disclosures, signage, website content and format, and civil remedies. It inc…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.